Objective: To develop recommendations for the use of methotrexate (MTX) in patients with rheumatoid arthritis.
Methods: Canadian rheumatologists who participated in the international 3e Initiative in Rheumatology (evidence, expertise, exchange) in 2007-2008 formulated 5 unique Canadian questions. A bibliographic team systematically reviewed the relevant literature on these 5 topics.